Cell line · CVCL_7935
Papers38
1 to 20 of 38
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells. | Cells | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Histone deacetylase HDAC7 restricts CD8 + T cell tumor infiltration and limits immunotherapy sensitivity in bladder cancer: reversal by pinocembrin. | J Exp Clin Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| 5'-S-(3-Aminophenyl)-5'-thioadenosine, a Novel Chemoprotective Agent for Reducing Toxic Side Effects of Fluorouracil in Treatment of MTAP-Deficient Cancers. | Mol Cancer Ther | 2025 | Its Methods give the RRID and name the line | PubMed | |
| HLA-E and NKG2A Mediate Resistance to BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer. | bioRxiv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Full-course NIR-II imaging-navigated fractionated photodynamic therapy of bladder tumours with X-ray-activated nanotransducers. | Nat Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Proteomic analysis of the urothelial cancer landscape. | Nat Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer. | Cancer Cell | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Next-generation characterization of the Cancer Cell Line Encyclopedia. | Nature | 2019 | Cellosaurus cites it | PubMed | |
| Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines. | Bladder Cancer | 2018 | Cellosaurus cites it | PubMed | |
| Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response. | Oncogene | 2017 | Cellosaurus cites it | PubMed | |
| Erratum to: The UBC-40 Urothelial Bladder Cancer Cell Line Index: a genomic resource for functional studies. | BMC Genomics | 2015 | Cellosaurus cites it | PubMed | |
| TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression. | Genome Med | 2015 | Cellosaurus cites it | PubMed | |
| The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies. | BMC Genomics | 2015 | Cellosaurus cites it | PubMed | |
| Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine. | Eur Urol | 2014 | Cellosaurus cites it | PubMed | |
| Identification of mutations in distinct regions of p85 alpha in urothelial cancer. | PLoS One | 2013 | Cellosaurus cites it | PubMed | |
| TSC1 involvement in bladder cancer: diverse effects and therapeutic implications. | J Pathol | 2013 | Cellosaurus cites it | PubMed | |
| PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. | Cancer Res | 2006 | Cellosaurus cites it | PubMed | |
| Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro. | Genes Chromosomes Cancer | 2005 | Cellosaurus cites it | PubMed | |
| Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization. | Cancer Genet Cytogenet | 2002 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_7935/papers